Spineguard Financials
| ALSGD Stock | EUR 0.21 0.01 4.55% |
Spineguard |
Understanding current and past Spineguard Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Spineguard's financial statements are interrelated, with each one affecting the others. For example, an increase in Spineguard's assets may result in an increase in income on the income statement.
Spineguard Stock Summary
Spineguard competes with Biophytis, and Novacyt. The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011464452 |
| Business Address | 10 Cours Louis |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.spineguard.com |
| Phone | 33 1 45 18 45 19 |
| Currency | EUR - Euro |
You should never invest in Spineguard without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Spineguard Stock, because this is throwing your money away. Analyzing the key information contained in Spineguard's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Spineguard Key Financial Ratios
Spineguard's financial ratios allow both analysts and investors to convert raw data from Spineguard's financial statements into concise, actionable information that can be used to evaluate the performance of Spineguard over time and compare it to other companies across industries.Spineguard Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spineguard's current stock value. Our valuation model uses many indicators to compare Spineguard value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spineguard competition to find correlations between indicators driving Spineguard's intrinsic value. More Info.Spineguard is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spineguard's earnings, one of the primary drivers of an investment's value.Spineguard Systematic Risk
Spineguard's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Spineguard volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Spineguard correlated with the market. If Beta is less than 0 Spineguard generally moves in the opposite direction as compared to the market. If Spineguard Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Spineguard is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Spineguard is generally in the same direction as the market. If Beta > 1 Spineguard moves generally in the same direction as, but more than the movement of the benchmark.
Spineguard November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Spineguard help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Spineguard. We use our internally-developed statistical techniques to arrive at the intrinsic value of Spineguard based on widely used predictive technical indicators. In general, we focus on analyzing Spineguard Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Spineguard's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.15 | |||
| Information Ratio | 0.1205 | |||
| Maximum Drawdown | 59.38 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 16.67 |
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.